{"name": "Viamet Pharmaceuticals",
 "permalink": "viamet-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/viamet-pharmaceuticals",
 "homepage_url": "http://www.viamet.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "919-467-8539",
 "description": "Drug Developer",
 "created_at": "Thu Sep 24 23:01:54 UTC 2009",
 "updated_at": "Wed Mar 17 10:59:00 UTC 2010",
 "overview": "\u003Cp\u003EViamet Pharmaceuticals discovers and develops \u0026#8220;best-in-class\u0026#8221; inhibitors of validated metalloenzymes via an innovative and proprietary metal-binding approach, their Metallophile\u00e2\u201e\u00a2 Technology. Viamet\u0026#8217;s disruptive Metallophile\u00e2\u201e\u00a2 technology is based on their world-class expertise in bioinorganic chemistry and metalloenzymes and allows them to identify validated targets with high therapeutic and commercial potential; leverage existing metalloenzyme inhibitors as the basis for Viamet\u0026#8217;s best-in-class analogs; and rapidly and cost-effectively generate best-in-class, patentable, small molecule compounds by optimizing the metal-binding component of existing inhibitors. \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       46],
      "assets/images/resized/0006/3580/63580v1-max-150x150.jpg"],
     [[250,
       77],
      "assets/images/resized/0006/3580/63580v1-max-250x250.jpg"],
     [[255,
       79],
      "assets/images/resized/0006/3580/63580v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$22M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "http://www.fiercebiotech.com/story/viamet-gets-big-pharma-support-18m-round/2009-07-07",
    "source_description": "Viamet gets Big Pharma support in $18M round Read more: http://www.fiercebiotech.com/story/viamet-gets-big-pharma-support-18m-round/2009-07-07#ixzz0S4Hjz62O",
    "raised_amount": 18000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 7,
    "funded_day": 7,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Novartis Option Fund",
         "permalink": "novartis-option-fund",
         "image":
          {"available_sizes":
            [[[150,
               19],
              "assets/images/resized/0007/3160/73160v1-max-150x150.png"],
             [[250,
               32],
              "assets/images/resized/0007/3160/73160v1-max-250x250.png"],
             [[373,
               49],
              "assets/images/resized/0007/3160/73160v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Lilly Ventures",
         "permalink": "lilly-ventures",
         "image":
          {"available_sizes":
            [[[150,
               71],
              "assets/images/resized/0005/5135/55135v3-max-150x150.png"],
             [[240,
               114],
              "assets/images/resized/0005/5135/55135v3-max-250x250.png"],
             [[240,
               114],
              "assets/images/resized/0005/5135/55135v3-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "InterSouth Partners",
         "permalink": "intersouth-partners",
         "image":
          {"available_sizes":
            [[[150,
               43],
              "assets/images/resized/0002/9315/29315v2-max-150x150.png"],
             [[250,
               71],
              "assets/images/resized/0002/9315/29315v2-max-250x250.png"],
             [[403,
               116],
              "assets/images/resized/0002/9315/29315v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Hatteras Venture Partners",
         "permalink": "hatteras-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               39],
              "assets/images/resized/0004/6917/46917v2-max-150x150.png"],
             [[250,
               65],
              "assets/images/resized/0004/6917/46917v2-max-250x250.png"],
             [[393,
               103],
              "assets/images/resized/0004/6917/46917v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Lurie Investment Fund",
         "permalink": "lurie-investment-fund",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Astellas Venture Management",
         "permalink": "astellas-venture-management",
         "image":
          {"available_sizes":
            [[[150,
               60],
              "assets/images/resized/0004/6637/46637v3-max-150x150.png"],
             [[160,
               64],
              "assets/images/resized/0004/6637/46637v3-max-250x250.png"],
             [[160,
               64],
              "assets/images/resized/0004/6637/46637v3-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "a",
    "source_url": "http://findarticles.com/p/articles/mi_m0EIN/is_2007_June_7/ai_n27267020/",
    "source_description": "Viamet Pharmaceuticals Raises $4 Million Round of Financing",
    "raised_amount": 4000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2007,
    "funded_month": 6,
    "funded_day": 7,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Hatteras Venture Partners",
         "permalink": "hatteras-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               39],
              "assets/images/resized/0004/6917/46917v2-max-150x150.png"],
             [[250,
               65],
              "assets/images/resized/0004/6917/46917v2-max-250x250.png"],
             [[393,
               103],
              "assets/images/resized/0004/6917/46917v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "InterSouth Partners",
         "permalink": "intersouth-partners",
         "image":
          {"available_sizes":
            [[[150,
               43],
              "assets/images/resized/0002/9315/29315v2-max-150x150.png"],
             [[250,
               71],
              "assets/images/resized/0002/9315/29315v2-max-250x250.png"],
             [[403,
               116],
              "assets/images/resized/0002/9315/29315v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "2250 Perimeter Park Drive",
    "address2": "Suite 320",
    "zip_code": "27560",
    "city": "Morrisville",
    "state_code": "NC",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        118],
       "assets/images/resized/0006/3581/63581v1-max-150x150.jpg"],
      [[250,
        197],
       "assets/images/resized/0006/3581/63581v1-max-250x250.jpg"],
      [[450,
        355],
       "assets/images/resized/0006/3581/63581v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}